Notification of cessation of +securities

Announcement Summary

For personal use only

Entity name

ZELIRA THERAPEUTICS LIMITED

Announcement Type

New announcement

Date of this announcement

Monday February 21, 2022

Details of +securities that have ceased

Number of

ASX +security

+securities that

The +securities have

Date of

code

Security description

have ceased

ceased due to

cessation

ZLDAA

OPTION EXPIRING

25,000,000 Expiry of option or other

19/02/2022

VARIOUS DATES EX

convertible security without

VARIOUS PRICES

exercise or conversion

Refer to next page for full details of the announcement

Notification of cessation of +securities

1 / 6

Notification of cessation of +securities

Part 1 - Announcement Details

For personal use only

1.1 Name of +Entity

ZELIRA THERAPEUTICS LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2

Registered Number Type

Registration Number

ABN

27103782378

1.3

ASX issuer code

ZLD

  1. The announcement is New announcement
  2. Date of this announcement

21/2/2022

Notification of cessation of +securities

2 / 6

Notification of cessation of +securities

Part 2 - Details of +equity securities or +debt securities that have ceased

For personal use only

ASX +Security Code and Description

ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased

5,000,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

Is the entity paying any consideration for the cessation?

19/2/2022

No

Any other information the entity wishes to notify to ASX about the cessation?

Exercisable at $0.10 on or before 19 February 2022

ASX +Security Code and Description

ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased

5,000,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

Is the entity paying any consideration for the cessation?

19/2/2022

No

Any other information the entity wishes to notify to ASX about the cessation?

Exercisable at $0.15 on or before 19 February 2022

ASX +Security Code and Description

ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased

5,000,000

Notification of cessation of +securities

3 / 6

Notification of cessation of +securities

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

For personal use only

Date of cessation

Is the entity paying any consideration for the cessation?

19/2/2022

No

Any other information the entity wishes to notify to ASX about the cessation?

Exercisable at $0.30 on or before 19 February 2022

ASX +Security Code and Description

ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased

5,000,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

Is the entity paying any consideration for the cessation?

19/2/2022

No

Any other information the entity wishes to notify to ASX about the cessation?

Exercisable at $0.20 on or before 19 February 2022

ASX +Security Code and Description

ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased

5,000,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

Is the entity paying any consideration for the cessation?

19/2/2022

No

Any other information the entity wishes to notify to ASX about the cessation?

Exercisable at $0.28 on or before 19 February 2022

Notification of cessation of +securities

4 / 6

Notification of cessation of +securities

For personal use only

Notification of cessation of +securities

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Zelda Therapeutics Ltd. published this content on 21 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 February 2022 03:10:08 UTC.